1.39
Schlusskurs vom Vortag:
$1.465
Offen:
$1.45
24-Stunden-Volumen:
59,507
Relative Volume:
0.26
Marktkapitalisierung:
$6.36M
Einnahmen:
$895.50K
Nettoeinkommen (Verlust:
$-26.30M
KGV:
-0.0212
EPS:
-65.5728
Netto-Cashflow:
$-23.84M
1W Leistung:
-11.46%
1M Leistung:
-19.65%
6M Leistung:
-51.14%
1J Leistung:
-85.58%
Mainz Biomed N V Stock (MYNZ) Company Profile
Firmenname
Mainz Biomed N V
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MYNZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MYNZ
Mainz Biomed N V
|
1.39 | 7.93M | 895.50K | -26.30M | -23.84M | -65.57 |
|
TMO
Thermo Fisher Scientific Inc
|
565.24 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.83 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.12 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.08 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.96 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-14 | Eingeleitet | Maxim Group | Buy |
| 2024-11-25 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | Eingeleitet | H.C. Wainwright | Buy |
Mainz Biomed N V Aktie (MYNZ) Neueste Nachrichten
Is Mainz Biomed NV a good long term investmentWeekly Market Snapshot & Invest With Confidence - earlytimes.in
Is a relief rally coming for Mainz Biomed N.V. holdersGold Moves & High Yield Equity Trading Tips - newser.com
Will Mainz Biomed N.V. (4TO) stock return to pre crash levelsTrade Entry Summary & Weekly Breakout Stock Alerts - newser.com
Building trade automation scripts for Mainz Biomed N.V.Trade Signal Summary & High Win Rate Trade Tips - newser.com
What margin trends mean for Mainz Biomed N.V. stockEarnings Growth Summary & Weekly Market Pulse Updates - newser.com
How Mainz Biomed N.V. (4TO) stock performs in easing cyclesEarnings Overview Report & Real-Time Buy Zone Alerts - newser.com
Will Mainz Biomed N.V. (4TO) stock rise with strong economyPortfolio Value Summary & Accurate Trade Setup Notifications - newser.com
Why Mainz Biomed N.V. (4TO) stock attracts wealthy investorsJuly 2025 Macro Moves & Weekly Consistent Profit Watchlists - newser.com
Using portfolio simulators with Mainz Biomed N.V. includedTake Profit & Low Risk Entry Point Tips - newser.com
Can Mainz Biomed N.V. stock continue upward trendEarnings Summary Report & Verified High Yield Trade Plans - newser.com
Can Mainz Biomed N.V. stock deliver strong Q4 earningsMarket Trend Review & Technical Analysis for Trade Confirmation - newser.com
Key resistance and support levels for Mainz Biomed N.V.Market Activity Report & Technical Pattern Based Signals - newser.com
Is Mainz Biomed N.V. stock ready for a breakoutBear Alert & Low Drawdown Momentum Ideas - newser.com
Can Mainz Biomed N.V. (4TO) stock sustain free cash flowJuly 2025 Earnings & Weekly Top Gainers Trade List - newser.com
Will Mainz Biomed N.V. (4TO) stock benefit from mergersJuly 2025 Opening Moves & Technical Buy Zone Confirmations - newser.com
How forex fluctuations impact Mainz Biomed N.V. (4TO) stock2025 Earnings Impact & Free Technical Pattern Based Buy Signals - newser.com
What’s the recovery path for long term holders of Mainz Biomed N.V.July 2025 Intraday Action & Growth Oriented Trade Recommendations - newser.com
Will Mainz Biomed N.V. outperform the marketTreasury Yields & High Accuracy Investment Entry Signals - newser.com
What to do if you’re stuck in Mainz Biomed N.V.Portfolio Value Summary & Weekly Market Pulse Updates - newser.com
Will Mainz Biomed N.V. stock remain a Wall Street favoriteEarnings Recap Summary & Real-Time Volume Analysis Alerts - newser.com
Is Mainz Biomed N.V. stock a safe investment in uncertain marketsWeekly Stock Recap & Real-Time Volume Surge Alerts - newser.com
What dividend safety score for Mainz Biomed N.V. stockFed Meeting & Community Trade Idea Sharing - fcp.pa.gov.br
Finanzdaten der Mainz Biomed N V-Aktie (MYNZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):